Baar, Switzerland Wednesday, March 4, 2026, 17:00 Hrs [IST] ...
CHMP adopts positive opinion on Moderna’s mRNA combination vaccine ‘mCOMBRIAX’ against influenza, Covid-19: Cambridge, Massachusetts Wednesday, March 4, 2026, 16:00 Hrs [IST ...
Ipsen receives CHMP’s positive opinion on Ojemda for treating monotherapy of children with relapsed or refractory BRAF-altered paediatric low-grade glioma: Paris Wednesday, Marc ...
Our Bureau, Chennai Wednesday, March 4, 2026, 13:30 Hrs [IST] The Kolathur Zone of the Tamil Nadu Chemists and Druggists Associat ...
Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...
Resmed’s global survey shows sleep is a top health priority, yet quality rest remains elusive for millions: Our Bureau, Bengaluru Wednesday, March 4, 2026, 11:45 Hrs [IST] Resme ...
Tarrytown, New York Wednesday, March 4, 2026, 13:00 Hrs [IST] ...
EMA recommends marketing authorisation to Norgine’s mavorixafor in patients aged 12 years and older to treat of WHIM syndrome: Amsterdam Wednesday, March 4, 2026, 12:00 Hrs [IST ...
Philips and ACTREC Tata Memorial Cancer Centre to strengthen early cancer detection in India with Spectral CT: Our Bureau, Bengaluru Wednesday, March 4, 2026, 11:30 Hrs [IST] Phil ...
Practo appoints Cijo George as vice president of AI as the company scales its outcome-driven healthcare platform globally: Our Bureau, Bengaluru Wednesday, March 4, 2026, 12:15 Hr ...
Merck presents positive results from phase 3 LITESPARK-022 trial of Keytruda plus Welireg in certain patients with earlier-stage RCC at 2026 ASCO cancers symposium: Rahway, New Je ...
CDSCO to replace SUGAM Portal with new digital platform to boost regulatory system digitisation: Shardul Nautiyal, Mumbai Wednesday, March 4, 2026, 08:00 Hrs [IST] In a significan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results